SwissMedic-2021-0069-V269

Major variation for application SwissMedic-2021-0069. Major variation: Container Closure Change for Atezolimumab-R — critical change

Variation Number
SwissMedic-2021-0069-V269
Type
Major
Application
SwissMedic-2021-0069
Change
CHG-2024-0269
Status
Approved
Fee
€75,605
Submitted
—
Approved
2024-04-10
Description

Major variation: Container Closure Change for Atezolimumab-R — critical change